Dyne Therapeutics has granted inducement equity awards to six newly hired employees under Nasdaq Listing Rule 5635(c)(4). The awards consist of non-statutory stock options to purchase up to an aggregate of 126,000 shares of common stock at an exercise price equal to the June 16, 2026 closing price, and restricted stock units covering an aggregate of 40,100 shares. The stock options have a ten-year term and vest over four years, with 25% vesting on the first anniversary and the remainder in 12 equal quarterly installments. The restricted stock units vest over four years in four equal annual installments, subject to continued service.
Dyne Therapeutics IncGrant of inducement equity awards to new employees is a routine capital event, not indicative of company performance.